Sangamo Therapeutics, Inc. ( SGMO) - Stock Earnings
SGMO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -34.9 million USD | 581000 USD |
| 2025Q4 | -37.4 million USD | 14.2 million USD |
| 2026Q1 | -31.0 million USD | 1.4 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SGMO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -257.8 million USD | 176.2 million USD |
| 2024 | -97.9 million USD | 57.8 million USD |
| 2025 | -122.9 million USD | 39.6 million USD |
| 2026 Est. | — | — |
SGMO
Price: $0.22
52 week price:
Earnings Per Share: -0.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 882100
Ebitda: -12.6 millionMarket Capitalization: 91.1 million